Immunoprofiling Reveals Cell Subsets Associated with the Trajectory of Cytomegalovirus Reactivation Post Stem Cell Transplantation

Overview

Journal Nat Commun

Specialty Biology

Date 2022 May 13

PMID 35546552

Authors

Lauren Stern

Helen M McGuire

Selmir Avdic

Barbara Fazekas de St. Groth

David Gottlieb

Allison Abendroth

Emily Blyth

Barry Slobedman

Affiliations

Soon will be listed here.

Abstract

Human cytomegalovirus reactivation is a major opportunistic infection after allogeneic haematopoietic stem cell transplantation and has a complex relationship with post-transplant immune reconstitution. Here, we use mass cytometry to define patterns of innate and adaptive immune cell reconstitution at key phases of human cytomegalovirus reactivation in the first 100 days post haematopoietic stem cell transplantation. Human cytomegalovirus reactivation is associated with the development of activated, memory T-cell profiles, with faster effector-memory CD4 T-cell recovery in patients with low-level versus high-level human cytomegalovirus DNAemia. Mucosal-associated invariant T cell levels at the initial detection of human cytomegalovirus DNAemia are significantly lower in patients who subsequently develop high-level versus low-level human cytomegalovirus reactivation. Our data describe distinct immune signatures that emerged with human cytomegalovirus reactivation after haematopoietic stem cell transplantation, and highlight Mucosal-associated invariant T cell levels at the first detection of reactivation as a marker that may be useful to anticipate the magnitude of human cytomegalovirus DNAemia.

Citing Articles

Cytotoxic KLRG1+ IL-7R- effector CD8+ T cells distinguish kidney transplant recipients controlling cytomegalovirus reactivation.

Sun Y, Sen S, Parmar R, Arakawa-Hoyt J, Cappelletti M, Rossetti M Front Immunol. 2025; 16:1542531.

PMID: 40028342 PMC: 11868092. DOI: 10.3389/fimmu.2025.1542531.

NK- and T-cell repertoire is established early after allogeneic HSCT and is imprinted by CMV reactivation.

Schafer A, Calderin Sollet Z, Herve M, Buhler S, Ferrari-Lacraz S, Norman P Blood Adv. 2024; 8(21):5612-5624.

PMID: 39047210 PMC: 11550366. DOI: 10.1182/bloodadvances.2024013117.

Application of mass cytometry to characterize hematopoietic stem cells in apheresis products of patients with hematological malignancies.

Villegas-Valverde C, Bencomo-Hernandez A, Castillo-Aleman Y, Ventura-Carmenate Y, Casado-Hernandez I, Rivero-Jimenez R Hematol Transfus Cell Ther. 2024; 46 Suppl 6:S59-S70.

PMID: 38177056 PMC: 11726105. DOI: 10.1016/j.htct.2023.10.008.

Circulating cytokine and chemokine patterns associated with cytomegalovirus reactivation after stem cell transplantation.

Stern L, McGuire H, Avdic S, Blyth E, Gottlieb D, Patrick E Clin Transl Immunology. 2023; 12(12):e16815.

PMID: 38034080 PMC: 10684332. DOI: 10.1002/cti2.1473.

Joint models quantify associations between immune cell kinetics and allo-immunological events after allogeneic stem cell transplantation and subsequent donor lymphocyte infusion.

Koster E, Bonneville E, von dem Borne P, van Balen P, Marijt E, Tjon J Front Immunol. 2023; 14:1208814.

PMID: 37593737 PMC: 10427852. DOI: 10.3389/fimmu.2023.1208814.

References

Avetisyan G, Aschan J, Hagglund H, Ringden O, Ljungman P . Evaluation of intervention strategy based on CMV-specific immune responses after allogeneic SCT. Bone Marrow Transplant. 2007; 40(9):865-9. DOI: 10.1038/sj.bmt.1705825. View

Li L, Chen H, Marin D, Xi Y, Miao Q, Lv J . A novel immature natural killer cell subpopulation predicts relapse after cord blood transplantation. Blood Adv. 2019; 3(23):4117-4130. PMC: 6963241. DOI: 10.1182/bloodadvances.2019000835. View

Sattler A, Dang-Heine C, Reinke P, Babel N . IL-15 dependent induction of IL-18 secretion as a feedback mechanism controlling human MAIT-cell effector functions. Eur J Immunol. 2015; 45(8):2286-98. DOI: 10.1002/eji.201445313. View

Hengst J, Strunz B, Deterding K, Ljunggren H, Leeansyah E, Manns M . Nonreversible MAIT cell-dysfunction in chronic hepatitis C virus infection despite successful interferon-free therapy. Eur J Immunol. 2016; 46(9):2204-10. DOI: 10.1002/eji.201646447. View

Ingham A, Kielsen K, Cilieborg M, Lund O, Holmes S, Aarestrup F . Specific gut microbiome members are associated with distinct immune markers in pediatric allogeneic hematopoietic stem cell transplantation. Microbiome. 2019; 7(1):131. PMC: 6744702. DOI: 10.1186/s40168-019-0745-z. View

El Haddad L, Ariza-Heredia E, Shah D, Jiang Y, Blanchard T, Ghantoji S . The Ability of a Cytomegalovirus ELISPOT Assay to Predict Outcome of Low-Level CMV Reactivation in Hematopoietic Cell Transplant Recipients. J Infect Dis. 2018; 219(6):898-907. PMC: 6386808. DOI: 10.1093/infdis/jiy592. View

Schluter J, Peled J, Taylor B, Markey K, Smith M, Taur Y . The gut microbiota is associated with immune cell dynamics in humans. Nature. 2020; 588(7837):303-307. PMC: 7725892. DOI: 10.1038/s41586-020-2971-8. View

Bhattacharyya A, Hanafi L, Sheih A, Golob J, Srinivasan S, Boeckh M . Graft-Derived Reconstitution of Mucosal-Associated Invariant T Cells after Allogeneic Hematopoietic Cell Transplantation. Biol Blood Marrow Transplant. 2017; 24(2):242-251. PMC: 5806215. DOI: 10.1016/j.bbmt.2017.10.003. View

Knight A, Madrigal A, Grace S, Sivakumaran J, Kottaridis P, Mackinnon S . The role of Vδ2-negative γδ T cells during cytomegalovirus reactivation in recipients of allogeneic stem cell transplantation. Blood. 2010; 116(12):2164-72. DOI: 10.1182/blood-2010-01-255166. View

10.

Lugthart G, van Ostaijen-Ten Dam M, Jol-van der Zijde C, van Holten T, Kester M, Heemskerk M . Early cytomegalovirus reactivation leaves a specific and dynamic imprint on the reconstituting T cell compartment long-term after hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2014; 20(5):655-61. DOI: 10.1016/j.bbmt.2014.01.018. View

11.

Teira P, Battiwalla M, Ramanathan M, Barrett A, Ahn K, Chen M . Early cytomegalovirus reactivation remains associated with increased transplant-related mortality in the current era: a CIBMTR analysis. Blood. 2016; 127(20):2427-38. PMC: 4874224. DOI: 10.1182/blood-2015-11-679639. View

12.

Raeiszadeh M, Pachnio A, Begum J, Craddock C, Moss P, Chen F . Characterization of CMV-specific CD4+ T-cell reconstitution following stem cell transplantation through the use of HLA Class II-peptide tetramers identifies patients at high risk of recurrent CMV reactivation. Haematologica. 2015; 100(8):e318-22. PMC: 5004434. DOI: 10.3324/haematol.2015.123687. View

13.

Ussher J, Willberg C, Klenerman P . MAIT cells and viruses. Immunol Cell Biol. 2018; 96(6):630-641. PMC: 6055725. DOI: 10.1111/imcb.12008. View

14.

Reeves M, Sinclair J . Circulating dendritic cells isolated from healthy seropositive donors are sites of human cytomegalovirus reactivation in vivo. J Virol. 2013; 87(19):10660-7. PMC: 3807413. DOI: 10.1128/JVI.01539-13. View

15.

Fabrizio V, Rodriguez-Sanchez M, Mauguen A, Dahi P, Doubrovina E, OReilly R . Adoptive therapy with CMV-specific cytotoxic T lymphocytes depends on baseline CD4+ immunity to mediate durable responses. Blood Adv. 2021; 5(2):496-503. PMC: 7839363. DOI: 10.1182/bloodadvances.2020002735. View

16.

Bosch M, Dhadda M, Hoegh-Petersen M, Liu Y, Hagel L, Podgorny P . Immune reconstitution after anti-thymocyte globulin-conditioned hematopoietic cell transplantation. Cytotherapy. 2012; 14(10):1258-75. PMC: 3681879. DOI: 10.3109/14653249.2012.715243. View

17.

Munoz-Cobo B, Solano C, Benet I, Costa E, Remigia M, de la Camara R . Functional profile of cytomegalovirus (CMV)-specific CD8+ T cells and kinetics of NKG2C+ NK cells associated with the resolution of CMV DNAemia in allogeneic stem cell transplant recipients. J Med Virol. 2011; 84(2):259-67. DOI: 10.1002/jmv.22254. View

18.

Green M, Leisenring W, Stachel D, Pergam S, Sandmaier B, Wald A . Efficacy of a viral load-based, risk-adapted, preemptive treatment strategy for prevention of cytomegalovirus disease after hematopoietic cell transplantation. Biol Blood Marrow Transplant. 2012; 18(11):1687-99. PMC: 3467354. DOI: 10.1016/j.bbmt.2012.05.015. View

19.

Kheav V, Busson M, Scieux C, Peffault de Latour R, Maki G, Haas P . Favorable impact of natural killer cell reconstitution on chronic graft-versus-host disease and cytomegalovirus reactivation after allogeneic hematopoietic stem cell transplantation. Haematologica. 2014; 99(12):1860-7. PMC: 4258747. DOI: 10.3324/haematol.2014.108407. View

20.

Duke E, Williamson B, Borate B, Golob J, Wychera C, Stevens-Ayers T . CMV viral load kinetics as surrogate endpoints after allogeneic transplantation. J Clin Invest. 2020; 131(1). PMC: 7773411. DOI: 10.1172/JCI133960. View